Insider Trading
Filed: 2026-04-22
Key Insights
- Chief Medical Officer Craig Kevin James exercised 42,579 stock options at $5.00 per share on 04/20/2026, generating approximately $212,895 in proceeds, followed by an immediate sale indicating profit-taking rather than confidence-building accumulation.
- The insider executed transactions under a Rule 10b5-1 trading plan adopted on 12/19/2025, suggesting pre-planned, methodical liquidation rather than opportunistic buying, which is typically a bearish signal for insiders with material information.
- James acquired 27,280 shares at $1.50 and 15,299 shares at $1.84 through option exercises, but the same-day sale of 42,579 shares at $5.00 demonstrates net selling pressure with zero net accumulation of common stock by this senior executive.
- Following the reported transactions, James maintains 706,859 and 372,701 stock options respectively with expiration dates in 2034-2035, but his direct common stock ownership decreased significantly, indicating reduced confidence in near-term stock performance.